|
CN103735519A
|
|
Deferasirox granules and preparation method thereof
|
|
CN103720654A
|
|
Aripiprazole micro-emulsion preparation and preparation method thereof
|
|
CN103728393A
|
|
Method for separating and measuring deferasirox raw material related substances by liquid chromatography
|
|
CN103724239A
|
|
Preparation method of 3-(3-phenylamidosulfonyl-phenyl)-acrylate
|
|
CN103724238A
|
|
Preparation method of (1R, 2R)-1, 2-cyclohexanedimethanol diaryl sulphonate
|
|
CN103772257A
|
|
Method for preparing 2-((3s)-3-hydroxy pyrrolidine-1-yl)-(1s)-1-phenethyl carbamate
|
|
CN103816153A
|
|
Application of compound DZCY06 in preparation of drugs for treating diabetes
|
|
CN104513182A
|
|
Method for preparing (1R,2R)-1,2-cyclohexanedimethanol disulfonate
|
|
CN104513233A
|
|
Novel method for preparing 5-(4-(4-(5-cyano-1H-indole-3-yl)butyl)piperazine-1-yl)coumarone-2-methanamide
|
|
CN104045631A
|
|
Novel method for preparing 5-(4-(4-(5-cyano-1H-indolyl-3-yl)butyl)piperazinyl-1-yl)benzofuryl-2-methanamide
|
|
CN103910717A
|
|
Novel 5-(4-(4-(5-cyan-1H-indole-3-group)butyl)piperazine-1-group)coumarone-2-formic acid preparation method
|
|
CN102813640A
|
|
Soft capsule containing desloratadine and preparation method thereof
|
|
CN102807540A
|
|
Novel method for preparing 5-aminobenzene-2-formic acid
|
|
CN102631329A
|
|
Oral paroxetine disintegrating tablet and preparation process thereof
|
|
CN103304527A
|
|
Novel preparation method of 5-nitrobenzofuran-2-formic acid
|
|
CN103304526A
|
|
Novel preparation method of 5-(piperazin-yl)benzofuran-2-formic acid
|
|
CN103156860A
|
|
Olanzapine composition and preparation method thereof
|
|
CN102784097A
|
|
Stable prasugrel hydrobromide solid preparation and preparation method thereof
|
